drug
flibanserin
Marketedupdated 3mo agoby Sprout2 Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Trials studying flibanserin
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 9, 2028
~1.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- May 9, 2028method-of-use (U-1734)US 71511031.7y
FDA exclusivities (1)
- Dec 13, 2028I-983Indication (3y)2.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that